Name: | Clenbuterol |
---|---|
PubChem Compound ID: | 10588797 |
Description: | A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. |
Molecular formula: | C12H18Cl2N2O |
Molecular weight: | 280.208 g/mol |
Name: | Clenbuterol |
---|---|
Name (isomeric): | DB01407 |
Drug Type: | small molecule |
Description: | A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. |
Synonyms: |
Clenbuterolum [inn-latin]
|
Brand: | Planipart |
Category: | Adrenergic beta-Agonists, Sympathomimetics, Bronchodilator Agents |
CAS number: | 37148-27-9 |
Indication: | Used as a bronchodilator in the treatment of asthma patients. |
---|---|
Pharmacology: | Clenbuterol is a substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. Although approved for use in some countries, as of fall, 2006, clenbuterol is not an ingredient of any therapeutic drug approved by the U.S. Food and Drug Administration. |
Mechanism of Action: | Clenbuterol is a Beta(2) agonist similar in some structural respects to salbutamol. Agonism of the beta(2) receptor stimulates adenylyl cyclase activity which ultimately leads to downstream effects of smooth muscle relaxation in the bronchioles. |
Absorption: | 89-98% orally |
Half Life: | 36-39 hours |
Affected organisms: | Humans and other mammals |